These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 6713900

  • 21. [Current concepts of the role of aluminum in chronic kidney failure patients].
    Gruev I, Belovezhdov N.
    Vutr Boles; 1983; 22(2):1-4. PubMed ID: 6362201
    [No Abstract] [Full Text] [Related]

  • 22. Changes in bone histology after treatment with desferrioxamine.
    Ott SM, Andress DL, Nebeker HG, Milliner DS, Maloney NA, Coburn JW, Sherrard DJ.
    Kidney Int Suppl; 1986 Feb; 18():S108-13. PubMed ID: 3457986
    [No Abstract] [Full Text] [Related]

  • 23. [The role of aluminum in the human body].
    Strzałkowska D.
    Postepy Hig Med Dosw; 1991 Feb; 45(3-4):257-79. PubMed ID: 1946095
    [Abstract] [Full Text] [Related]

  • 24. Aluminum and renal bone disease in Australia.
    Dunstan CR, Evans RA.
    Kidney Int Suppl; 1986 Feb; 18():S65-9. PubMed ID: 3457999
    [No Abstract] [Full Text] [Related]

  • 25. [Water purification in dialysis treatment. Aluminum and encephalopathy].
    Hagstam KE, Lindergård B, Lindholm T, Thysell H.
    Lakartidningen; 1980 Jun 25; 77(26-27):2425-7. PubMed ID: 7401791
    [No Abstract] [Full Text] [Related]

  • 26. [Kinetics of aluminum absorption and serum concentration in chronic renal insufficiency].
    Sárszegi Z, Jobst K, Nagy J.
    Orv Hetil; 2000 Aug 27; 141(35):1915-7. PubMed ID: 11019592
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.
    Nebeker HG, Andress DL, Milliner DS, Ott SM, Alfrey AC, Slatopolsky EA, Sherrard DJ, Coburn JW.
    Kidney Int Suppl; 1986 Feb 27; 18():S96-9. PubMed ID: 3458006
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A fatal case of aluminium encephalopathy in a patient with severe chronic renal failure not on dialysis.
    Zatta P, Zambenedetti P, Reusche E, Stellmacher F, Cester A, Albanese P, Meneghel G, Nordio M.
    Nephrol Dial Transplant; 2004 Nov 27; 19(11):2929-31. PubMed ID: 15496577
    [No Abstract] [Full Text] [Related]

  • 34. Dialysate aluminium concentration and renal bone disease.
    Walker GS, Aaron JE, Peacock M, Robinson PJ, Davison AM.
    Kidney Int; 1982 Feb 27; 21(2):411-5. PubMed ID: 7070002
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Acute aluminemic encephalopathy in chronic renal failure: the citrate factor.
    Bakir AA.
    Int J Artif Organs; 1989 Dec 27; 12(12):741-3. PubMed ID: 2613353
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.